Back to Water glossary

Water glossary

Disinfection Byproducts (DBPs) and Health Effects in Drinking Water

Explore the health impacts of disinfection byproducts (DBPs) in drinking water, including carcinogenicity, reproductive effects, and regulatory standards.

Introduction: The Double-Edged Sword of Disinfection

Drinking water disinfection has dramatically reduced waterborne diseases globally, saving countless lives. However, the chemical processes involved can inadvertently create a new set of challenges: Disinfection Byproducts (DBPs). These compounds form when disinfectants, such as chlorine, react with natural organic matter and other precursors in the raw water. Over the past three decades, the potential health risks associated with DBPs have garnered significant attention, particularly since the discovery of chloroform in chlorinated drinking water.

Understanding Disinfection Byproduct Research

Research into the health effects of DBPs is multifaceted, primarily focusing on two key areas:

  • Human Epidemiological Studies: These investigations analyze long-term health outcomes in populations exposed to disinfected drinking water, aiming to identify correlations between DBP exposure and specific health conditions. Such studies typically involve exposure to low DBP concentrations over many years.
  • Laboratory Animal Studies: Conducted on animals, these studies evaluate the toxicity of individual DBPs and their mixtures. They often involve controlled exposure to various DBP concentrations to understand their mechanisms of action and potential health impacts.

Challenges in Laboratory Animal Research

Studying DBPs in laboratory animals presents several complexities:

  • Diversity of DBPs: A vast number of DBPs can form, making comprehensive testing challenging.
  • Varied Health Endpoints: Cancer, for instance, can manifest through diverse biological pathways.
  • Species-Specific Responses: Different animal species may react dissimilarly to the same DBPs.

Despite these challenges, animal research often prioritizes DBPs with the highest human exposure rates and known toxicity.

Key Findings from Laboratory Animal Studies

  • Reproductive Effects: Rat studies examined sperm motion after controlled exposures to bromodichloromethane (BDCM), chloral hydrate (CH) and other DBPs. These experimental findings concern the tested doses and endpoints; they do not establish human reproductive effects at an unspecified low drinking-water concentration. (Klinefelter, 1996)
  • Carcinogenicity of DBP Mixtures: A 2002 study exposed Eker rats (known for sensitivity to renal carcinogens) to mixtures of dichloromethylhydroxyfuranone (MX), potassium bromate (KBrO3_3), chloroform (CHCl3_3), and bromodichloromethane (BDCM) in drinking water for 4 to 10 months. These DBPs were selected for their proven renal carcinogenic or nephrotoxic properties. While a dose-response relationship for renal cancer was observed, the study found no significant difference in tumor rates in kidneys, uterus, or spleen between rats exposed to the mixture versus the single DBP with the strongest effect. This suggests that the combined effect of these specific DBPs was not greater than the most potent individual DBP. (Hooth, 2002)
  • Effects of Chlorine Dioxide, Chlorite, and Chlorate: An animal-study review reported dose-related blood changes at high experimental concentrations: chlorine dioxide up to 1 g/L (1000 mg/L) and sodium chlorite/chlorate up to 100 mg/L (100,000 µg/L). Hematological findings and differences with exposure duration should not be generalized to all animals or to ordinary human drinking-water exposure. Effects and dose-response relationships require substance-specific assessment. (Couri, 1982)
  • Chloroform Toxicity: Animal responses vary with dose, route, species and target tissue. Large bolus doses can cause cytotoxicity and regenerative cell growth, mechanisms considered important in tumor formation. Drinking-water administration does not universally prevent cancer; kidney tumors have also occurred in high-dose water studies. EPA's final assessment from 2001 describes carcinogenicity under exposure conditions causing sustained cytotoxicity and cell regeneration, rather than declaring all drinking-water exposure risk-free. (Larson, 1994a; Larson et al., 1994b; Butterworth et al., 1998; EPA, 2001)

Human Health Effects of Disinfection Byproducts

Beyond animal studies, extensive epidemiological research investigates the impact of DBP exposure on human health, primarily focusing on cancer and reproductive/developmental effects.

Carcinogenic Effects

Analytical advances revealed many organic substances in drinking water. The four regulated THMs are chloroform, bromoform, bromodichloromethane and dibromochloromethane; dichloromethane and dibromomethane are not members of that group. Occurrence and hazard vary, so they should not all be described as proven human carcinogens present in every chlorinated water.

  • Challenges in Proving Causality: In 1991, the WHO's International Agency for Research on Cancer (IARC) concluded that definitively linking cancer development to chlorinated water is difficult due to the small risk, inaccuracies in DBP exposure estimation, and numerous confounding factors (e.g., smoking, diet, genetics, socioeconomic status). (Disinfectants and Disinfection Byproducts, WHO, 2001)

  • Bladder and Rectal Cancer:

    • A historical meta-analysis reported associations with bladder and rectal cancer, not anal cancer. Estimated attributable fractions such as 9% and 15% depend on the populations, exposure surrogates and modeling assumptions; they are not established contemporary case counts or the percentage attributable to a single DBP. (Morris, 1992)
    • Studies in Colorado (1990-1991) showed that the risk of bladder cancer increased with years of exposure to chlorinated drinking water. After 30 years of exposure, the risk was 1.8 times higher than for unexposed individuals. (McGeehin, 1993)
    • Research in Ontario, Canada, found a link between long-term DBP exposure and bladder cancer, particularly with trihalomethane (THM) concentrations of 50 µg/L (0.05 mg/L) or more. This study attributed 14-16% of all bladder cancer cases to DBP exposure. (King, 1996)
    • Finnish research found a significant connection between exposure to mutagenic and carcinogenic substances in drinking water and bladder cancer for both men and women, and renal cancer for men. (Koivusalo, 1998)
    • While individual risk may be small, the widespread and long-term exposure of populations to chlorinated drinking water makes the overall public health impact of DBP-related bladder cancer significant. (Kogevinas, 2003)
  • Intestinal Cancer:

    • Some studies, like one in Ontario, Canada, involving 5000 people, suggested an elevated risk of intestinal cancer (1.5 times higher) for individuals exposed to THM concentrations of 50 µg/L (0.05 mg/L) or more. (Marret & King, 1995)
    • Other studies in Iowa, USA, reported different findings for colon and rectal cancer. Differences in exposure assessment, water composition and other factors complicate comparisons; Iowa is not in Canada. (Mills, 1998)
  • Rectal Cancer: A case-control study in Iowa, USA (1986-1989), evaluated colon and rectal cancer separately. It reported associations for rectal cancer in some exposure comparisons, with modification by dietary fiber and physical activity, rather than an established causal effect on anal cancer. (Hildesheim, 1998)

Reproductive and Developmental Effects

Laboratory and epidemiological research has also investigated reproductive and developmental endpoints. Experimental concentrations, species and exposure routes matter; an effect in an animal pregnancy study cannot establish a human effect or a universal concentration threshold. Comparisons with cancer doses across unrelated studies are not reliable. (Singer, 1999)

  • Trihalomethanes (THMs): Epidemiological studies, though few, indicate a connection between THM exposure and spontaneous abortion, birth defects, and growth delay. (Wigle, 1998)
  • Chlorine Dioxide Byproducts (Chlorite, Chlorate):
    • A historical comparison of communities using chlorine or high chlorine dioxide levels reported an association with physician-assessed prematurity and greater weight loss after birth. These are not equivalent to proven low birth weight caused by the disinfectant. The authors described the findings as suggestive, and later evaluation highlighted confounding and inconsistent prematurity measures. (Tuthill, 1982)
    • Conversely, a Norwegian study (1993-1995) of 137,145 births found no connection between exposure to chlorinated drinking water (even with high organic matter) and low birth weight or small body length. It even suggested a slightly smaller risk of premature birth with chlorinated water compared to non-chlorinated. (Jaakkola, 2001)
    • An Italian study (1988-1989) reported associations between disinfection practices and some infant measurements. DBP concentrations were not directly measured, and exposure classification and other factors limit causal interpretation. Reduced maternal immunity should not be presented as an established mechanism. (Kanitz, 1996)
  • Birth Defects:
    • A Norwegian study (1993-1998) of 285,631 births found associations between DBP exposure during pregnancy and heart, breathing, and urine tract defects, with a significant increase in abdominal wall defects at higher exposures. (Bing-Fang, 2002)
    • Massachusetts data (1990) for 56,513 births showed THM concentrations of 80 µg/L (0.08 mg/L) or more were associated with a 32-gram reduction in birth weight and smaller body length (fetal growth delay), but no link to premature birth. (Wright, 2003)
    • Research in Nova Scotia, Canada (1988-1995), indicated that bromodichloromethane concentrations of 20 µg/L (0.02 mg/L) or more during pregnancy were linked to an elevated risk of neural tube defects, and chloroform exposure to an elevated risk of chromosomal defects. (Dodds, 2001)
    • A Swedish study (2001) of 59,422 children found an elevated risk of heart and artery defects when both chlorine dioxide and hypochlorite were used, suggesting that chlorine dioxide might increase this risk, even when THM levels were below standard limits. (Cedergren, 2001)
  • Reliability of Reproduction Studies: Many studies show a probable link between exposure to chlorinated DBPs during pregnancy and birth defects, particularly low birth weight and growth delay. However, evidence for spontaneous abortion, specific birth defects, and still-birth is often inconsistent and lacks a strong dose-effect relationship. This may be due to varied research methods and challenges in accurately determining individual exposure. (Graves, 2001; Nieuwenhuijsen, 2000) More precise measurements of DBP concentrations at the tap, accounting for seasonal and annual variations, are needed. (Reif, 1996)

Recommendations for Disinfection Byproduct Control

The primary objective is microbiologically safe drinking water. WHO advises that DBP control must not compromise adequate disinfection; the relative risks depend on the pathogen, treatment failure and chemical exposure rather than a universal numerical ratio. The cholera epidemic beginning in Peru in 1991 illustrates the importance of safe water and sanitation, but its full regional case and death totals cannot be assigned to inadequate chlorination alone.

Nevertheless, DBP risks, though low, cannot be ignored due to widespread exposure. Continuous research is needed to identify uncharacterized DBPs, assess their individual and combined health effects, and understand their mutagenic potential.

Control Methods for Disinfection Byproducts

Effective DBP control strategies aim to minimize their formation without compromising disinfection efficacy:

  1. Pre-Disinfection Organic Matter Removal: This is the most effective approach. Removing natural organic matter (NOM) before disinfectant application reduces the available precursors for DBP formation. Techniques include:
    • Coagulation/Flocculation: To remove particles and turbidity.
    • Activated Carbon: To adsorb organic substances.
    • Membrane Filtration: To physically remove organic matter.
  2. Alternative Disinfectants and Oxidants: Different agents can reduce selected DBP classes while introducing other constraints. Validate microbial inactivation and distribution protection; an oxidant is not automatically an adequate primary disinfectant. Options to assess include:
    • Ozone
    • Chlorine Dioxide
    • Potassium Permanganate for relevant oxidation or precursor-control duties, rather than assuming it replaces validated primary disinfection
    • Chloramines (though these can form nitrogenous DBPs)
  3. Optimization of Disinfectant Application Point: Adjusting where and when disinfectants are added can minimize reaction time with precursors.
  4. Post-Disinfection DBP Removal: In some cases, technologies can be applied after disinfection to remove DBPs already formed.

Regulatory Standards for Disinfection Byproducts

Regulatory requirements and WHO guidance have different legal roles. Hazard classifications also differ by agency, assessment date and compound; the IARC chloroform classification is possibly carcinogenic to humans (Group 2B), and should not be assigned unchanged to all THMs. The table retains selected historical values; the WHO entries reflect the older guidance cited here, not a complete current compliance list. Later WHO guidance gives chloroform 300 µg/L and dibromochloromethane 100 µg/L, and a mixture rule based on individual concentration-to-guideline ratios.

RegulatorDBP ParameterStandard Value
EUTotal Trihalomethanes100 µg/L (0.1 mg/L)
WHOBromodichloromethane60 µg/L (0.06 mg/L)
Bromoform100 µg/L (0.1 mg/L)
Chloroform200 µg/L (0.2 mg/L)
USA (EPA)Total Trihalomethanes (TTHM)80 µg/L (0.08 mg/L)
Haloacetic Acids (HAA5)60 µg/L (0.06 mg/L)

The U.S. EPA's Stage 1 Disinfectants and Disinfection Byproducts Rule (1998) includes precursor-removal treatment requirements for applicable conventional surface-water systems, with specified criteria and exceptions. It does not mandate enhanced coagulation for every water system. Stage 2 also specifies monitoring and compliance calculations that must be considered. (EPA, 2001)

Learn more about formation and types of disinfection byproducts.

AquaChain Engineering Tip

Prioritize upstream treatment processes, such as enhanced coagulation or membrane filtration, to remove Natural Organic Matter (NOM) before primary disinfection. This proactive precursor removal strategy is often more cost-effective and environmentally sound than trying to remove DBPs after they have formed.


Frequently Asked Questions

Q1: Why are Disinfection Byproducts (DBPs) a concern if disinfection is essential for safe drinking water?

A1: While disinfection is crucial for eliminating harmful pathogens, the chemicals used can react with natural organic matter to form DBPs. The concern arises from potential long-term health effects associated with DBP exposure, such as increased cancer risks and reproductive issues, even at low concentrations.

Q2: What are the primary health effects linked to DBP exposure in drinking water?

A2: Research primarily points to two categories of health effects:

  1. Carcinogenic effects: Studies have reported associations particularly for bladder cancer and some rectal or colorectal outcomes; findings vary and do not prove that every DBP is the cause.
  2. Reproductive and developmental effects: These include associations with low birth weight, growth delay, premature birth, and certain birth defects.

Q3: How can water treatment facilities minimize the formation of DBPs?

A3: DBP formation can be minimized by several strategies, including:

  1. Precursor Removal: Removing natural organic matter (NOM) before disinfection through processes like enhanced coagulation, activated carbon, or membrane filtration.
  2. Alternative Disinfectants: Using disinfectants like ozone, chlorine dioxide, or chloramines, which produce different or fewer regulated DBPs compared to free chlorine.
  3. Process Optimization: Adjusting the point of disinfectant application, contact time, and pH to reduce DBP formation while maintaining effective pathogen kill.